Literature DB >> 24816859

Primary hypertrophic osteoarthropathy caused by homozygous deletion in HPGD gene in a family: changing clinical and radiological findings with long-term follow-up.

Beyhan Tüysüz1, Saliha Yılmaz, Özgür Kasapçopur, Tuğba Erener-Ercan, Emre Ceyhun, Kaya Bilguvar, Murat Günel.   

Abstract

Autosomal recessive primary hypertrophic osteoarthropathy1 (PHOAR1) is characterized by delayed closure of the fontanels, digital clubbing, arthropathy and periostosis. Homozygous mutations in hydroxyprostaglandin dehydrogenase (HPGD) gene are the underlying pathology of PHOAR1. The aim of this study was to analyze the HPGD gene and the changing clinical and radiological findings with advancing age of two siblings with the diagnosis of PHOAR1. A novel 2-bp homozygous deletion was found in exon 3 (c.310-311delCT) of HPGD gene in the patients. Clinical and radiological findings of the siblings were evaluated between 4 months and 8 years and 6 months of age. The painful swelling and sweating of the hands and feet, cranial ossification defect and expanded diaphyses were evident at infantile period and gradually showed improvement until 4 years of age. After the age of 4 years, digital clubbing and swelling of knees persisted, palmoplantar hyperkeratosis developed and acro-osteolysis became evident on hand radiographs. In conclusion, we suggest that the clinical findings of the patients with PHOAR1 should be classified in two periods as early and late childhood. We also observed that there was intrafamilial variability of clinical findings.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24816859     DOI: 10.1007/s00296-014-3037-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  13 in total

1.  HPGD mutations cause cranioosteoarthropathy but not autosomal dominant digital clubbing.

Authors:  Wenke Seifert; Julia Beninde; Katrin Hoffmann; Tom H Lindner; Christian Bassir; Fuat Aksu; Christoph Hübner; Nienke E Verbeek; Stefan Mundlos; Denise Horn
Journal:  Eur J Hum Genet       Date:  2009-07-01       Impact factor: 4.246

2.  Mutations in the prostaglandin transporter encoding gene SLCO2A1 cause primary hypertrophic osteoarthropathy and isolated digital clubbing.

Authors:  Wenke Seifert; Jirko Kühnisch; Beyhan Tüysüz; Christof Specker; Ad Brouwers; Denise Horn
Journal:  Hum Mutat       Date:  2012-02-24       Impact factor: 4.878

Review 3.  A novel homozygous splice site mutation in the HPGD gene causes mild primary hypertrophic osteoarthropathy.

Authors:  L Sinibaldi; G Harifi; I Bottillo; M Iannicelli; S El Hassani; F Brancati; B Dallapiccola
Journal:  Clin Exp Rheumatol       Date:  2010-05-13       Impact factor: 4.473

4.  Pachydermoperiostosis-critical analysis with report of five unusual cases.

Authors:  Anna Latos-Bielenska; Ivo Marik; Miroslaw Kuklik; Anna Materna-Kiryluk; Czeslaw Povysil; Kazimierz Kozlowski
Journal:  Eur J Pediatr       Date:  2007-02-07       Impact factor: 3.183

5.  Familial idiopathic hypertrophic osteoarthropathy and cranial suture defects in children.

Authors:  A J Reginato; V Schiapachasse; R Guerrero
Journal:  Skeletal Radiol       Date:  1982       Impact factor: 2.199

6.  Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy.

Authors:  Sandeep Uppal; Christine P Diggle; Ian M Carr; Colin W G Fishwick; Mushtaq Ahmed; Gamal H Ibrahim; Philip S Helliwell; Anna Latos-Bieleńska; Simon E V Phillips; Alexander F Markham; Christopher P Bennett; David T Bonthron
Journal:  Nat Genet       Date:  2008-05-25       Impact factor: 38.330

Review 7.  Cranio-osteoarthropathy: a rare variant of hypertrophic osteoarthropathy.

Authors:  X Chen; C C Zou; G P Dong; L Liang; Z Y Zhao
Journal:  Ir J Med Sci       Date:  2009-05-09       Impact factor: 1.568

8.  Cranio-osteoarthropathy in sibs.

Authors:  Tabib Dabir; A M Sills; Christine M Hall; Chris Bennett; Louise C Wilson; Raoul C M Hennekam
Journal:  Clin Dysmorphol       Date:  2007-07       Impact factor: 0.816

9.  Congenital cardiac disease as a core feature of cranio-osteoarthropathy.

Authors:  Susan O'Connell; Mohnish Suri; Desmond Duff; Jeremiah Kelleher; Christine M Hall; William Reardon
Journal:  Clin Dysmorphol       Date:  2004-10       Impact factor: 0.816

10.  Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis.

Authors:  Christine P Diggle; David A Parry; Clare V Logan; Paul Laissue; Carolina Rivera; Carlos Martín Restrepo; Dora J Fonseca; Joanne E Morgan; Yannick Allanore; Michaela Fontenay; Julien Wipff; Mathilde Varret; Laure Gibault; Nadezhda Dalantaeva; Márta Korbonits; Bowen Zhou; Gang Yuan; Ghita Harifi; Kivanc Cefle; Sukru Palanduz; Hadim Akoglu; Petra J Zwijnenburg; Klaske D Lichtenbelt; Bérengère Aubry-Rozier; Andrea Superti-Furga; Bruno Dallapiccola; Maria Accadia; Francesco Brancati; Eamonn G Sheridan; Graham R Taylor; Ian M Carr; Colin A Johnson; Alexander F Markham; David T Bonthron
Journal:  Hum Mutat       Date:  2012-05-29       Impact factor: 4.878

View more
  6 in total

1.  Compound Heterozygous Pathogenic Variants of the 15-Hydroxyprostaglandin Dehydrogenase Gene in a Patient With Hypertrophic Osteoarthropathy: First Case in Korea.

Authors:  Mi Ra Ryu; Ji Hyun Yang; Sang Youl Rhee; Ahra Cho; Seong Yoon Kim; Chang Seok Ki
Journal:  Ann Lab Med       Date:  2019-01       Impact factor: 3.464

2.  The first case of primary hypertrophic osteoarthropathy with soft tissue giant tumors caused by HPGD loss-of-function mutation.

Authors:  Qianqian Pang; Yuping Xu; Xuan Qi; Yan Jiang; Ou Wang; Mei Li; Xiaoping Xing; Ling Qin; Weibo Xia
Journal:  Endocr Connect       Date:  2019-06       Impact factor: 3.335

3.  Characterization of Mineral and Bone Metabolism Biomarkers in a Chinese Consanguineous Twin Family with Primary Hypertrophic Osteoarthropathy.

Authors:  Na Li; Yuhang Ma; Yun Jiang; Li You; Yunhong Huang; Yongde Peng; Xiaoying Ding; Li Zhao
Journal:  Int J Endocrinol       Date:  2020-12-03       Impact factor: 3.257

4.  Is an association of acro-osteolysis, bone fragility, and enchondromatosis a newfound disease caused by an amplification of PTHLH? A case report.

Authors:  Stéphane Echaubard; Céline Pebrel-Richard; Aurélie Chausset; Jean-Louis Kemeny; Etienne Merlin; Fanny Laffargue
Journal:  Pediatr Rheumatol Online J       Date:  2022-07-30       Impact factor: 3.413

5.  Clinical and biochemical characteristics of 12 Chinese primary hypertrophic osteoarthropathy patients with HPGD mutations.

Authors:  Qi Lu; Yang Xu; Shanshan Li; Zeng Zhang; Jiagen Sheng; Zhenlin Zhang
Journal:  Int J Biol Sci       Date:  2022-06-06       Impact factor: 10.750

6.  Novel SLCO2A1 mutations cause gender differentiated pachydermoperiostosis.

Authors:  Lijuan Yuan; Xihui Chen; Ziyu Liu; Dan Wu; Jianguo Lu; Guoqiang Bao; Sijia Zhang; lIfeng Wang; Yuanming Wu
Journal:  Endocr Connect       Date:  2018-08-01       Impact factor: 3.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.